Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula
Clinical trial NCT01011244 · COMPLETED
Trial details
- NCT number
- NCT01011244
- Sponsor
- Anterogen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.